To enact section 3701.136 of the Revised Code to create the Xeroderma Pigmentosum Research Commission.

Section 1. That section 3701.136 of the Revised Code be enacted to read as follows:

Sec. 3701.136.  (A) There is hereby created the xeroderma pigmentosum research commission consisting of members appointed by the director of health. Members shall include researchers, health care professionals, and persons personally affected by the disease.

(B) Not later than ninety days after the effective date of this section, the director shall make initial appointments to the commission. Terms of office shall be three years, with each term ending on the same day of the same month as did the term that it succeeds. Each member shall hold office from the date of appointment until the end of the term for which the member was appointed. Members may be reappointed.

Vacancies shall be filled in the same manner as original appointments. Any member appointed to fill a vacancy occurring prior to the expiration of the term for which the member's predecessor was appointed shall hold office for the remainder of that term. A member shall continue in office subsequent to the expiration date of the member's term until the member's successor takes office or until a period of sixty days has elapsed, whichever occurs first.

(C) The commission shall annually select from among its members a chairperson. The commission shall meet at the call of the chair, but not less than twice each year. A majority of the members constitutes a quorum.

(D) Members shall serve without compensation, but may be reimbursed for actual and necessary expenses incurred in the performance of their duties.

(E) The commission shall assist the director of health and research community in seeking a cure for xeroderma pigmentosum.